Literature DB >> 5462680

Fluorinated pyrimidines. XXXVII. Effects of 5-trifluoromethyl-2'-deoxyuridine on the synthesis of deoxyribonucleic acid of mammalian cells in culture.

Y Fujiwara, T Oki, C Heidelberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5462680

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN： 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  22 in total

Review 1.  TAS-102, a novel antitumor agent: a review of the mechanism of action.

Authors:  Heinz-Josef Lenz; Sebastian Stintzing; Fotios Loupakis
Journal:  Cancer Treat Rev       Date:  2015-06-06       Impact factor: 12.111

2.  HEp-2 cell- and herpes simplex virus type 1- induced deoxythymidine kinases: inhibition by derivatives of 5-trifluoromethyl-2'-deoxyuridine.

Authors:  B L Wigdahl; J R Parkhurst
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

3.  Efficacy and safety of trifluridine/tipiracil in third-line and beyond for the treatment of patients with metastatic colorectal cancer in routine clinical practice: patterns of use and prognostic nomogram.

Authors:  A Fernandez Montes; F Vazquez Rivera; N Martinez Lago; M Covela Rúa; A Cousillas Castiñeiras; P Gonzalez Villarroel; J de la Cámara Gómez; J C Méndez Méndez; M Salgado Fernández; S Candamio Folgar; M Reboredo López; M Carmona Campos; E Gallardo Martín; M Jorge Fernández; M L Pellón Augusto; L París Bouzas; J García Gómez
Journal:  Clin Transl Oncol       Date:  2019-05-09       Impact factor: 3.405

4.  Intracellular localization of drugs in cultured tumor cells by ion microscopy and image processing.

Authors:  J P Berry; G Lespinats; F Escaig; P Boumati; S Tlouzeau; J F Cavellier
Journal:  Histochemistry       Date:  1990

Review 5.  TAS-102: a novel antimetabolite for the 21st century.

Authors:  Nataliya Uboha; Howard S Hochster
Journal:  Future Oncol       Date:  2015-11-30       Impact factor: 3.404

6.  Synergistic anticancer activity of a novel oral chemotherapeutic agent containing trifluridine and tipiracil in combination with anti-PD-1 blockade in microsatellite stable-type murine colorectal cancer cells.

Authors:  Norihiko Suzuki; Hiroshi Tsukihara; Fumio Nakagawa; Takashi Kobunai; Teiji Takechi
Journal:  Am J Cancer Res       Date:  2017-10-01       Impact factor: 6.166

7.  New active drugs for the treatment of advanced colorectal cancer.

Authors:  Alberto Zaniboni
Journal:  World J Gastrointest Surg       Date:  2015-12-27

8.  Antitumor activity of FTC-092, a masked 5-trifluoromethyl-2'-deoxyuridine derivative.

Authors:  S Takeda; J Yamashita; H Saito; J Uchida; H Satake; Y Yamada; N Unemi; Y Wataya; H Hayatsu
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 9.  Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

10.  Trifluridine selectively inhibits cell growth and induces cell apoptosis of triple-negative breast cancer.

Authors:  Juan Li; Jie Liu; Riqi Wang; He Chen; Cui Li; Minggang Zhao; Fang He; Yaochun Wang; Peijun Liu
Journal:  Am J Cancer Res       Date:  2020-02-01       Impact factor: 6.166
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.